Category: Obsessive Compulsive and Related Disorders

Symposium

Symposium 10 - Innovations in the Treatment of Obsessive-Compulsive and Related Disorders

Friday, November 17
8:30 AM - 10:00 AM
Location: Sapphire Ballroom M & N, Level 4, Sapphire Level

Keywords: OCD (Obsessive Compulsive Disorder) | Body Dysmorphic Disorder | Hoarding
Presentation Type: Symposium

Disorders falling within the obsessive compulsive spectrum are linked by high comorbidities, common etiological factors, and similar phenomenological features. Despite our growing understanding of the nature of these disorders, treating patients with OC spectrum conditions remains a significant challenge. As recently as the 1970’s, OCD was considered untreatable, and this perception extended to related disorders, including Body Dysmorphic Disorder (BDD) and Hoarding Disorder. Through the development of exposure and response prevention and subsequent research on this form of cognitive behavioral therapy (CBT), the notion of these disorders reflecting intractable conditions has largely faded. Nevertheless, there remains room for improvement with respect to available evidence-based therapies. A sizeable percentage of patients do not respond to extant treatments, and concerns persist regarding the dissemination of established therapies. Furthermore, for many treatments the mechanism of action remains unclear, which hinders the development of newer, more efficacious therapies or the improvement of existing treatments. The current symposium will bring together an international group of experts to present new data on some of the most pressing questions facing the OC spectrum field: the development of effective treatments, predictors of treatment outcome, alternative treatment modalities, and consideration of mechanisms of action.

Dr. Sabine Wilhelm will present the primary outcome data on a large randomized controlled trial comparing CBT to supportive psychotherapy for BDD. Next, Dr. David Tolin will present data on predictors of treatment noncompliance and attrition in group CBT for Hoarding Disorder. Dr. Cornelia Exner will discuss issues of feasibility and mechanisms of actions for metacognitive therapy for OCD. Finally, Ryan Jacoby will present a translational study comparing gradual versus variable intensity of exposure for patients with OCD, in line with recent inhibitory learning theories. Jon Abramowitz will serve as the discussant, and will synthesize common themes across the presentations with a focus on the implications of the findings for the dissemination of evidence-based approaches. Consideration will be given to similarities and differences between the various OC-spectrum disorders and their treatment. Future avenues of research will also be addressed.

Learning Objectives:

Send Email for Kiara Timpano

Jonathan S. Abramowitz

Professor of Psychology and Neuroscience
University of North Carolina at Chapel Hill

Presentation(s):

Send Email for Jonathan Abramowitz

Send Email for Sabine Wilhelm

Send Email for David Tolin

Cornelia Exner

Professor
University of Marburg, Germany

Presentation(s):

Send Email for Cornelia Exner

Ryan J. Jacoby

Post-Doctoral Fellow
Massachusetts General Hospital/Harvard Medical School; University of North Carolina at Chapel Hill

Presentation(s):

Send Email for Ryan Jacoby


Assets

Symposium 10 - Innovations in the Treatment of Obsessive-Compulsive and Related Disorders



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Innovations in the Treatment of Obsessive-Compulsive and Related Disorders